On November 11, 2025, Sanofi and Regeneron announced that the FDA accepted for priority review its supplemental biologics license application ...

When you're hoarse, sending a voice message, presenting a project at a meeting, dictating an address to your car's navigation system, or simply having a phone call can be difficult."We're a ...

Amgen’s fair value target has seen a modest increase, now set at $318.51 compared to its previous level of $311.88. Recent ...